| |
| |
|
| Insider
Information: |
Baluch Khoso |
| Relationship: |
|
| City: |
Bedminster |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
103,860 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$331,197 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
103,860 |
|
|
| Total
Value |
$331,197 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 51.1%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cormedix Inc. |
CRMD |
|
2020-08-13 |
60,905 |
2016-12-09 |
0 |
Premium* |
|
|
Processa Pharmaceuticals, Inc. |
PCSA |
|
2023-06-27 |
27,955 |
2023-02-09 |
0 |
Premium* |
|
|
Longeveron Inc. |
LGVN |
|
2023-12-29 |
15,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGVN |
Longeveron Inc. |
|
– • – |
2023-12-29 |
4 |
B |
$1.43 |
$11,915 |
D/D |
8,322 |
15,000 |
0.01 |
% |
|
| LGVN |
Longeveron Inc. |
|
– • – |
2023-12-28 |
4 |
B |
$1.40 |
$2,342 |
D/D |
1,678 |
6,678 |
0.01 |
% |
|
| PCSA |
Processa Pharmaceuticals,... |
|
• • – |
2023-06-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,455 |
27,955 |
0 |
- |
|
| LGVN |
Longeveron Inc. |
|
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| PCSA |
Processa Pharmaceuticals,... |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.80 |
$10,000 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2020-08-13 |
4 |
B |
$4.14 |
$19,985 |
D/D |
4,830 |
60,905 |
0.01 |
% |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2020-03-18 |
4 |
B |
$2.61 |
$9,135 |
D/D |
3,500 |
56,075 |
0.01 |
% |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2019-03-26 |
4 |
B |
$7.55 |
$18,875 |
D/D |
2,500 |
52,575 |
0.01 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2018-11-27 |
4 |
B |
$1.21 |
$26,015 |
D/D |
21,500 |
250,373 |
0.01 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2018-11-26 |
4 |
B |
$1.28 |
$4,480 |
D/D |
3,500 |
228,873 |
0.01 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2017-12-12 |
4 |
B |
$0.48 |
$50,000 |
D/D |
104,166 |
225,373 |
0.01 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2017-08-18 |
4 |
B |
$0.42 |
$15,026 |
D/D |
36,207 |
121,207 |
0.01 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2017-05-17 |
4 |
B |
$0.48 |
$35,625 |
D/D |
75,000 |
85,000 |
2.81 |
- |
|
| CRMD |
Cormedix Inc. |
Chief Executive Officer |
• • – |
2016-12-09 |
4 |
B |
$1.77 |
$17,700 |
D/D |
10,000 |
10,000 |
2.81 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
